天津护理 ›› 2025, Vol. 33 ›› Issue (3): 301-305.DOI: 10.3969/j.issn.1006-9143.2025.03.010

• 循证护理 • 上一篇    下一篇

艾滋病实施肾脏替代治疗患者死亡相关危险因素的Meta分析

申继传1 刘平芳2 张仙娟3 李中正4 张群红4 刘娟1   

  1. (1.邵阳市中心医院,湖南 邵阳 422000;2.湖南医药学院总医院;3.大理大学;4.吉首大学医学院)
  • 出版日期:2025-06-28 发布日期:2025-06-23
  • 基金资助:
    湖南省卫生健康委科研计划项目(202214014593)

Risk factors associated with mortality in patients with AIDS receiving renal replacement therapy: a meta analysis

SHEN Jichuan1, LIU Pingfang2, ZHANG Xianjuan3, LI Zhongzheng4, ZHANG Qunhong4, LIU Juan1   

  1. (1.The Central Hospital of Shaoyang, Shaoyang Hunan 422000; 2.Hunan University of Medicine General Hospital; 3.Dali University; 4.Jishou University School of Medicine)
  • Online:2025-06-28 Published:2025-06-23

摘要: 目的:通过Meta分析系统评价艾滋病实施肾脏替代治疗患者死亡的相关危险因素。方法:计算机检索Cochrane Library、PubMed、Web of Science、Embase、万方、中国知网、维普数据库中已发表的关于艾滋病实施肾脏替代治疗患者死亡相关危险因素,检索时段为自建库至2023年5月13日,采用RevMan 5.3进行Meta分析。结果:共纳入9篇文献,包含25项相关的危险因素。其中,高龄[HR=1.21,95%CI(1.12,1.32)]是艾滋病实施肾脏替代治疗患者死亡的危险因素;缺乏高效抗逆转录病毒治疗[HR=0.47,95%CI(0.32,0.69)]、住院时间长[HR=0.94,95%CI(0.90,0.98)]、身体质量指数(BMI)正常(18.5 kg/m2≤BMI<24 kg/m2)[HR=0.34,95%CI(0.17,0.68)]、超重及肥胖(BMI≥24 kg/m2)[HR=0.41,95%CI(0.23,0.72)]是艾滋病实施肾脏替代治疗患者死亡的保护因素。结论:高龄是艾滋病实施肾脏替代治疗患者死亡的危险因素,缺乏高效抗逆转录病毒治疗、住院时间长、BMI正常、超重及肥胖是保护因素。医护人员应采取针对性干预措施以降低患者死亡发生率。

关键词: 艾滋病, 肾脏替代治疗, 死亡, 危险因素, Meta分析

Abstract: Objective: To evaluate the risk factors associated with death in patients with AIDS receiving renal replacement therapy by meta-analysis system. Methods: Cochrane Library, PubMed, Web of Science, Embase, Wanfang, CNKI, and VIP were searched for the risk factors associated with death in patients with AIDS combined with renal replacement therapy from the inception to May 13, 2023, and meta-analysis was performed by using RevMan 5.3. Results: A total of 9 papers containing 25 relevant risk factors were included. Among them, advanced age [HR=1.21, 95%CI (1.12, 1.32)] was a risk factor for death in patients with AIDS receiving renal replacement therapy (P<0.001). Lack of highly active antiretroviral therapy (HAART) [HR=0.47, 95%CI (0.32, 0.69)], prolonged hospitalization [HR=0.94, 95%CI (0.90, 0.98)], normal body mass index (BMI) (18.5 kg/m2 ≤ BMI <24 kg/m2) [HR=0.34, 95%CI (0.17, 0.68)], overweight and obesity (BMI ≥24 kg/m2) [HR=0.41, 95%CI(0.23, 0.72)] were protective factors for death in patients with AIDS receiving renal replacement therapy (P<0.001). Conclusion: Advanced age is a risk factor for death in patients with AIDS receiving renal replacement therapy, and lack of HAART, prolonged hospitalisation, normal BMI, overweight and obesity are protective factors. The targeted intervention measures should be taken to reduce the prevelence of death.

Key words: AIDS, Renal replacement therapy, Death, Risk factors, Meta-analysis